Categories
Issue 78 August 2026

Nirsevimab for the prevention of Respiratory Syncytial Virus (RSV)

The 2026-2027 RSV Infant Immunisation Programme will officially launch on 27 August. Healthcare professionals will play an important role in delivering the programme and supporting parents to protect their babies against RSV. Below are some key clinical updates to support you as we prepare for this year’s programme. Nirsevimab (Beyfortus®, Sanofi) is a long-acting monoclonal […]

Categories
Issue 76 January 2026

Addressing Misinformation

Vaccine misinformation has been in the news recently. When someone has concerns or worries about vaccines, the advice that a trusted healthcare professional gives is very influential (Malik et al. Behavioural Interventions for vaccination uptake: A systematic review and meta-analysis).  There is good evidence that when a trusted healthcare professional talks to a person about their vaccine concerns in an empathetic and […]

Categories
Issue 76 January 2026

Children coming to Ireland from countries using Oral Polio Vaccine (OPV)

Since 2016, as recommended by the World Health Organization (WHO) all oral polio vaccines (OPV) vaccines provide protection against two types of polio virus (1 and 3) only.  WHO advised that children vaccinated with OPV vaccine since 2016 should also receive inactivated polio vaccine (IPV) x 2 to complete Primary immunisation against polio infection.  IPV still provides […]